Literature DB >> 33374294

Bone Regeneration Capacity of Newly Developed Uncalcined/Unsintered Hydroxyapatite and Poly-l-lactide-co-glycolide Sheet in Maxillofacial Surgery: An In Vivo Study.

Huy Xuan Ngo1, Quang Ngoc Dong1, Yunpeng Bai1, Jingjing Sha1, Shinji Ishizuka1, Tatsuo Okui1, Shintaro Sukegawa2, Takahiro Kanno1.   

Abstract

Uncalcined/unsintered hydroxyapatite and poly-l-lactide-co-glycolide (u-HA/PLLA/PGA) is a new bioresorbable nanomaterial with superior characteristics compared with current bioresorbable materials, including appropriate mechanical properties, outstanding bioactive/osteoconductive features, and remarkably shorter resorption time. Nevertheless, the bone regeneration characteristics of this nanomaterial have not been evaluated in maxillofacial reconstructive surgery. In this study, we used a rat mandible model to assess the bone regeneration ability of u-HA/PLLA/PGA material, compared with uncalcined/unsintered hydroxyapatite and poly-l-lactide acid (u-HA/PLLA) material, which has demonstrated excellent bone regenerative ability. A 4-mm-diameter defect was created at the mandibular angle area in 28 Sprague Dawley male rats. The rats were divided into three groups: u-HA/PLLA/PGA (u-HA/PLLA/PGA graft + defect), u-HA/PLLA (u-HA/PLLA graft + defect), and sham control (defect alone). At 1, 3, 8, and 16 weeks after surgeries, the rats were sacrificed and assessed by micro-computed tomography, histological analysis with hematoxylin and eosin staining, and immunohistochemical analyses. The results confirmed that the accelerated bone bioactive/regenerative osteoconduction of u-HA/PLLA/PGA was comparable with that of u-HA/PLLA in the rat mandible model. Furthermore, this new regenerative nanomaterial was able to more rapidly induce bone formation in the early stage and had great potential for further clinical applications in maxillofacial reconstructive surgery.

Entities:  

Keywords:  Runx2; bone regeneration; leptin receptor; osteocalcin; osteoconductivity; poly-l-lactic acid; poly-l-lactide-co-glycolide; uncalcined/unsintered hydroxyapatite

Year:  2020        PMID: 33374294     DOI: 10.3390/nano11010022

Source DB:  PubMed          Journal:  Nanomaterials (Basel)        ISSN: 2079-4991            Impact factor:   5.076


  5 in total

1.  Feasibility of Application of the Newly Developed Nano-Biomaterial, β-TCP/PDLLA, in Maxillofacial Reconstructive Surgery: A Pilot Rat Study.

Authors:  Erina Toda; Yunpeng Bai; Jingjing Sha; Quang Ngoc Dong; Huy Xuan Ngo; Takashi Suyama; Kenichi Miyamoto; Yumi Matsuzaki; Takahiro Kanno
Journal:  Nanomaterials (Basel)       Date:  2021-01-25       Impact factor: 5.076

Review 2.  A Narrative Review of u-HA/PLLA, a Bioactive Resorbable Reconstruction Material: Applications in Oral and Maxillofacial Surgery.

Authors:  Huy Xuan Ngo; Yunpeng Bai; Jingjing Sha; Shinji Ishizuka; Erina Toda; Rie Osako; Akira Kato; Reon Morioka; Mrunalini Ramanathan; Hiroto Tatsumi; Tatsuo Okui; Takahiro Kanno
Journal:  Materials (Basel)       Date:  2021-12-26       Impact factor: 3.623

Review 3.  Polylactide Perspectives in Biomedicine: From Novel Synthesis to the Application Performance.

Authors:  Carmen Moya-Lopez; Joaquín González-Fuentes; Iván Bravo; David Chapron; Patrice Bourson; Carlos Alonso-Moreno; Daniel Hermida-Merino
Journal:  Pharmaceutics       Date:  2022-08-11       Impact factor: 6.525

4.  Research on the osteogenesis and biosafety of ECM-Loaded 3D-Printed Gel/SA/58sBG scaffolds.

Authors:  Guozhong Tan; Rongfeng Chen; Xinran Tu; Liyang Guo; Lvhua Guo; Jingyi Xu; Chengfei Zhang; Ting Zou; Shuyu Sun; Qianzhou Jiang
Journal:  Front Bioeng Biotechnol       Date:  2022-08-17

5.  Bioactive Regeneration Potential of the Newly Developed Uncalcined/Unsintered Hydroxyapatite and Poly-l-Lactide-Co-Glycolide Biomaterial in Maxillofacial Reconstructive Surgery: An In Vivo Preliminary Study.

Authors:  Shinji Ishizuka; Quang Ngoc Dong; Huy Xuan Ngo; Yunpeng Bai; Jingjing Sha; Erina Toda; Tatsuo Okui; Takahiro Kanno
Journal:  Materials (Basel)       Date:  2021-05-10       Impact factor: 3.623

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.